##
##
##
##
##
||||||Page|
|---|---|---|---|---|---|
|Trustees'
annual
report (incorporating||the|director's|report)||
|Independent
examiner's
report to the||trustees||||
|Statement offinancial|activities (including||income and|||
|expenditure
account)||||||
|Statement offinancial|position|||||
|Notes to the financial|statements||||11-22|
##
##
##
##
##
|Reference|and adm|inistrative
|inistrative
|details|
|---|---|---|---|---|
|Registered|charity|name||The Livewell Foundation|
|Charity registration||number||1172401|
|Company|registration||number|10524700|
|Principal office and||registered||Local Care Centre|
|office||||200 Mount Gould Road|
|||||Mount Gould|
|||||Plymouth|
|||||United
Kingdom|
|||||PL4 7PY|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||2022||2021|
|---|---|---|---|---|---|---|---|
|||||Unrestricted|Restricted|||
|||||funds|funds|Total funds|Total funds|
||||Note|8|8|K|5|
|Income and endowments||||||||
|Donations
and legacies|||5|114,636|433|115,069|198,086|
|Total income||||114,636|433|115,069|198,086|
|Expenditure||||||||
|Expenditure
on charitable||activities|6,7|38,917|12,612|51,529|248,025|
|Total expenditure||||38,917|12,612|51,529|248,025|
|Net income/(expenditure)||and net||||||
|movement
in funds||||75,719|(12,179)|63,540|(49,939)|
|Reconciliation
offunds||||||||
|Total funds brought|forward|||184,024|245,671|429,695|479,634|
|Total funds carried|forward|||259,743|233,492|493,235|429,695|
##
##
##
|||||2022|2021|
|---|---|---|---|---|---|
||||Note|5|6|
|Current asseta||||||
|Debtors|||||753|
|Cash at bank and|in|hand||508,641|428,942|
|||||508,641|429,695|
|Net current asseR||||508,641|429,695|
|Total assets less|current liabilities|||508,641|429,695|
|Creditors: amounts||falling due after more than one year|12|15,406||
|Net assets||||493,235|429,695|
|Funds ofthe charity||||||
|Restricted
funds||||233,492|245,671|
|Unrestricted
funds||||||
|Designated
funds||||25,548|25,109|
|General funds||||234,195|158,915|
|Total charity funds|||14|493,235|429,695|
##
##
##
||||||2022|2021|
|---|---|---|---|---|---|---|
|Cash flows from operating|activities||||||
|Net cash used
in operating|activities||||63,540|~49 938|
|Increase/(Decrease)
in debtors|||||753|(754)|
|Increase/(Decrease)
in creditors|||||15,406|~16,779|
|Net cash generated
from operating||activities|||79,699|~17,533|
|Cash flows from financing|activities||||||
|Net cash provided
by financing
activities|||||||
|Change
in cash and cash|equivalents||in|the period|79,699|(67,471)|
|Cash and cash equivalents|at the beginning|||ofthe period|428,942|496413|
|Cash and cash equivalents|at the end||of|the period|508,641|428 942|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Donations
and legacies||||
|---|---|---|---|
||Unrestricted|Restricted|Total Funds|
||Funds|Funds|2022|
|Donations||||
|Donations|14,636||14,636|
|Legacies||||
|Legacies||433|433|
|Grants||||
|Grants receivable|100,000||100,000|
||114,636|433|115,069|
||Unrestricted|Restricted|Total Funds|
||Funds|Funds|2021|
||5||5|
|Donations||||
|Donations|13,498||13,498|
|Legacies||||
|Legacies|8,888|75,700|84,588|
|Grants||||
|Grants receivable|100,000||100,000|
||122,386|75,700|198,086|
##
##
##
##
##
##
||||Unrestricted|Restricted|Total|
|---|---|---|---|---|---|
||||funds|funds|funds|
||||2022|2022|2022|
||||6|6|K|
|Other funds|||32,413||32,413|
|Other legacy||||||
|Mount Gould Legacy||||12,612|12,612|
|Plym Neuro Fund|||1,147||1,147|
|Tavistock General|Fund||5,357||5,357|
|Livewell Southwest|CIC Grant|||||
||||38,917|12,612|51,529|
||||Unrestricted|Restricted|Total|
||||funds|funds|funds|
||||2021|2021|2021|
|||||6|K|
|Other funds|||787|800|1,587|
|Otherlegacy|||172|2,166|2,338|
|Mount Gould Legacy||||136,064|136,064|
|Plym Neuro Fund|||8,102||8,102|
|Tavistock General|Fund||1,934||1,934|
|Livewell Southwest|CIC Grant||98,000||98,000|
||||108,995|139,030|248,025|
|7.Analysis ofexpenditure||by Fund||||
||||Grant funding|Direct|Total|
||||ofactivities|expenditure|funds|
||||2022f|2022
6|2022
6|
|Other funds||||32,413|32,413|
|Other legacy||||||
|Mount Gould Legacy||||12,612|12,612|
|Plym Neuro Fund||||1,147|1,147|
|Tavistock General|Fund|||5,357|5,357|
|Livewell Southwest|CIC Grant|||||
|||||51 529|51,529|
||||Grant funding|Direct|Total|
||||ofactivities|expenditure|funds|
||||2021
8|2021f|2021f|
|Other funds||||1,587|1,587|
|Other legacy||||2,337|2,337|
|Mount Gould Legacy||||136,064|136,064|
|Plym Neuro Fund||||8,103|8,103|
|Tavistock General|Fund|||1,934|1,934|
|Livewell Southwest|CIC Grant||98000||98000|
||||98000|150025|248,025|
##
##
##
##
##
##
|8.Analysis ofexp|endit|ure
by Fund|(Continued)||||||
|---|---|---|---|---|---|---|---|---|
|||||||Support||Totalfunds|
|||||||Costs
2022f||2022f|
|Otherfunds||||||32,413||32,413|
|Otherlegacy|||||||||
|Mount Gould Legacy||||||12,612||12,612|
|Plym Neuro Fund||||||1,147||1,147|
|Tavistock General|Fund|||||5,357||5,357|
|||||||51,529||51,529|
|||||||Support||Totalfunds|
|||||||Costs
2021f||2021f|
|Other funds||||||1,587||1,587|
|Other legacy
Mount Gould Legacy||||||2,338
136,064||2,338
136,064|
|Plym Neuro Fund||||||8,102||8,102|
|Tavistock General|Fund|||||1,934||1 934|
|||||||150025||150025|
|Analysis ofsupport costs|||||||||
|||Other|Other|Mount|Plym|Tavistock||Total|
|||funds|legacies|Gould|Neuro|General||funds|
|||2022f|2022f|legacy
2022f|2022f|2022f||2022f|
|Staff development|||||||||
|Equipment
Grants||26,740||13,258|255|5,357||45,610|
|Staff and patient||1,242||225|1,100|||2,567|
|welfare and amenities|||||||||
|Support Costs||4,431||871|208|||3,352|
|||32,413||12,012|1 147|5|307|01,529|
|||Other|Other|Mount|Plym|Tavistock||Total|
|||funds|legacies|Gould|Neuro|General||funds|
|||2021f|2021f|legacy
2021f|2021f|2021||2021|
|Staff development||||791|100|||891|
|Equipment
Grants||4,378||103,128|5,850|1,762||115,118|
|Staff and patient||622||27,407|1,011|||29,040|
|welfare and amenities
Support Costs||@33413
~1587|2 330
2,338|4,738
136,064|1,141
8,102|1|172
934|~4975
150024|
##
##
##
##
##
##
##
##
|11.|During the period en
Debtors|ded 31 March 2022, no Trustee expenses
have|been incurred
(20|21 -fNIL)|
|---|---|---|---|---|
||||2022|2021|
||||E|E|
||Trade debtors|||753|
|12.|Creditors: amounts|falling due after more than one year|||
||||2022
f|2021
E|
||Trade creditors||15,406||
##
|Financial||Instruments|||||
|---|---|---|---|---|---|---|
||||||2022
E|2021
f|
|Financial||assets|||||
|Financial||assets measured|at fair value through|income and expenditure|506,641|428 942|
|Fi
i|I|IFF'litu|||||
|Financial||liabilities —creditors|||15,406||
##
##
##
##
##
##
||||Balance at|Income|Expenditure|Balance at|
|---|---|---|---|---|---|---|
||||1 April|5|K|31 March|
||||2021|||2022|
|||||||6|
|0 sl
at
U nm|ctsd|und|||||
|~07
~a1|||||||
|Plym Neuro Fund
Tavistock General Fund|||20,513
4,596
25,109|6,943
6,943|(1,147)
~5357
~6,504|26,309
~704
25,548|
|General funds|||||||
|Otherfunds|||42,199|7,693|(32,413)|17~79|
|Other legacies|||14,716|||14,716|
|Livewell Southwest|Grant||102,000
158,915|100,000
107,693|~32,413|202 000
234,195|
|Total Unrestricted|funds||184,024|114,636|~38017|259743|
|Restricted funds|||||||
|Mount Gould Legacy|||163,838||(12,612)|151,226|
|Plym Neuro Legacy|||9,098|||9,098|
|Westhourne
Legacy
Other funds|||73,535
~000
245,671|433
433|~12612|73,968
~000
233,492|
|~771 11
0|||420605|115000|~51029|493,235|
##
##
##
##
##
|Statements
offunds -prior period|Statements
offunds -prior period|Statements
offunds -prior period|||||
|---|---|---|---|---|---|---|
||||Balance at|Income|Expenditure|Balance at|
||||1 April|6|5|31 March|
||||2020
6|||2021f|
|t)eat
natedlunreetrlcted||funds|||||
|~OI
9
f|||||||
|Plym Neuro Fund
Tavistock General|Fund||26,098
2,514
28612|2,518
~,016
6534|(8,103)
~7.934
~701137|20,513
4596
25109|
|General funds|||||||
|Other funds|||36,021|6,964|(786)|42,199|
|Other legacies
Livewell Southwest|Grant||6,000
100,000
142021|8,888
100,000
115,852|(172)
~90,000
~80900|14,716
102,000
158,915|
|7 t 10
t
I t d|R d||170633|122306|~708995|184024|
|Restricted funds|||||||
|Mount Gould Legacy|||299,903||(136,065)|163,838|
|Plym Neuro Legacy|||9,098|||9,098|
|Westbourne
Legacy
Other funds|||309.001|75,700
75,700|(2,165)
~800
~738030|73,535
~800
245,671|
|~TI ff
d|||479,634|198.080|~248025|429,695|
##
##
##
##
##
##
|Summary
offunds —curre|nt period|||||
|---|---|---|---|---|---|
|||Balance
at 1 April|Income|Expendituref|Balance
at 31|
|||2021f|||March
2022f|
|Designated
funds
Generalfunds
Restricted funds||25,109
158,915
245,671
429,895|6,943
107,693
433
115090|(6,504)
(32,413)
~12612
~51529|25,548
234,195
233,492
493235|
|Summary
offunds —prior|period|||||
|||Balance
at 1 April|Incomef|Expenditure|Balance
at 31|
|||2020|||March|
|||F|||2021f|
|Designated
funds
General funds
Restricted funds||28,612
142,021
309,001
479,634|6,534
115,852
75 71IB
198,086|(10,037)
(98,958)
~139,030
~248,025|25,109
158,915
245671
429.695|
|16.Analysis ofnet assets|between|funds||||
|Analysis
of net assets|between|funds—||||
|Current year||||||
||||Unrestricted|Restricted|Total funds|
|Current assets
Creditors due within one
Total|year|funds
2022f
259,743
~4796
254,047||funds
2022f
248,898
508,641
~1II,~10 ~15,406
2022f
238288
493 235||
|Analysis
of net assets|between|funds—||||
|prior year||||||
||||Unrestricted|Restricted|Total funds|
||||funds
2021f|funds
2021
F|2021f|
|Current assets|||184,024|245 671|429,695|
|Total|||184024|245 671|428 695|
##
##
##
##
|17.Reconciliation|17.Reconciliation|of net|movement|movement|in funds to net cash flow from operating|in funds to net cash flow from operating|in funds to net cash flow from operating|activities||
|---|---|---|---|---|---|---|---|---|---|
|||||||||2022|2021|
|||||||||6|6|
|Net
income/expenditure
activities)|||for the year (as per Statement||||of Financial|63,540|(49,939)|
|Adjustments|for:|||||||||
|Decrease/(Increase)
Increase/(Decrease)
Net cash provided||in debtors
in creditors
by/(used
in) operating||||activities||753
46466
79,699|(753)
~16779,
~67,471|
|18.Analysis|ofcash and||cash equivalents|||||||
|||||||||2022f|2021|
|Cash in hand|||||||508,641||428,942|
|Total cash and cash equivalents|||||||508,641||428,942|
|19.Analysis|ofchanges
in|||net debt||||||
||||||||At 1 April|Cash|At 31|
||||||||2021|flows|March|
||||||||6|6|2022|
||||||||||6|
|Cash at bank|and in hand||||||426942|79,699|508,641|
||||||||428 942|79699|508641|
##
##